Background. Perioperative bleeding remains a major challenge in liver transplantation. We aimed to compare standard laboratory tests with thromboelastometry (ROTEM V R ) with regard to their ability to predict postoperative non-surgical bleeding. Methods. Data from 243 adult liver transplant recipients from January 2012 to May 2014 were evaluated retrospectively. Upon admission to the intensive care unit, coagulation status was assessed using standard laboratory tests [prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen concentration, and platelet count] and ROTEM V R whole blood coagulation assays. Bleeding was defined as transfusion of ! 3 units of red blood cells or reoperation for non-surgical bleeding within 48 h after transplantation. Coagulation test results were analysed using receiver operating characteristics (ROC) in order to identify variables predictive of postoperative bleeding. Coagulation management was based on ROTEM V Rguided factor concentrate treatment.
Background. Perioperative bleeding remains a major challenge in liver transplantation. We aimed to compare standard laboratory tests with thromboelastometry (ROTEM V R ) with regard to their ability to predict postoperative non-surgical bleeding. Methods. Data from 243 adult liver transplant recipients from January 2012 to May 2014 were evaluated retrospectively. Upon admission to the intensive care unit, coagulation status was assessed using standard laboratory tests [prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen concentration, and platelet count] and ROTEM V R whole blood coagulation assays. Bleeding was defined as transfusion of ! 3 units of red blood cells or reoperation for non-surgical bleeding within 48 h after transplantation. Coagulation test results were analysed using receiver operating characteristics (ROC) in order to identify variables predictive of postoperative bleeding. Coagulation management was based on ROTEM V Rguided factor concentrate treatment.
Results. The overall incidence of bleeding was 12.3% (n¼30). Twenty-three (9.5%) patients underwent reoperation and seven (2.9%) received !3 units of red blood cells and non-operative management. Standard laboratory tests predictive of postoperative bleeding were aPTT and PT [area under the ROC curve (AUC) 0.688 and 0.623, respectively]. Tests predictive of bleeding with ROTEM V R were CT EXTEM , CFT INTEM , A10 FIBTEM , and MCF FIBTEM , with AUCs of 0.682, 0.615, 0.615, and 0.611, respectively. Fibrinogen concentration, platelet count, and other ROTEM V R variables failed to demonstrate predictive value for postoperative bleeding (AUC <0.6). Dialysis-dependent kidney failure, 30 day mortality, and median model for endstage liver disease score were all significantly higher in bleeding patients. Conclusions. Although both postoperative standard laboratory tests and ROTEM V R assays could identify patients at risk for postoperative bleeding, ROTEM V R assays demonstrated a greater predictive value for impaired fibrinogen polymerizationrelated coagulopathy.
Even 50 yr after the first liver transplantation (LT), perioperative bleeding remains a major challenge. The development of algorithms for both predicting bleeding risk and assessment and treatment of clinical bleeding is extremely important. In most clinical settings, standard laboratory tests (SLTs), such as prothrombin time (PT), activated partial thromboplastin time (aPTT), and platelet count (PC), are used to guide coagulation management. [1] [2] [3] Unfortunately, long SLT turnaround times frequently delay targeted coagulation management. 4 5 As a consequence, clinicians frequently resort to a blanket approach when transfusing allogeneic blood products, resulting in unneccessary transfusions. 6 A recent meta-analysis evaluating the use of SLTs in the management of bleeding has raised serious questions regarding the practicality of this approach for coagulation management. 7 In contrast, viscoelastic tests, such as rotational thromboelastometry (ROTEM V R ) and thrombelastography (TEG V R ), might be superior compared with SLTs in guiding coagulation management in a variety of clinical settings, including LT. [8] [9] [10] [11] Although Ewe 12 demonstrated no correlation between SLTs and bleeding time in patients with cirrhosis, studies in cirrhotic patients have demonstrated a significant reduction in transfusions when using viscoelastic tests (TEG V R or ROTEM V R ) instead of laboratory assays. 13 14 Several studies, mainly from cardiac surgery, suggest that implementation of intraoperative viscoelastic testguided coagulation management protocols reduces allogeneic transfusions and hospital costs. 15 Similar data on their use in the intensive care unit (ICU) are not available. We aimed to compare postoperative SLTs and ROTEM V R analyses in predicting postoperative non-surgical bleeding in the ICU after LT.
Methods
This retrospective, single-centre, observational study was approved by the local ethics committee and followed the Declaration of Helsinki. Informed consent was waived because of the retrospective study design.
Patients
Two hundred and forty-five adult liver transplants performed from January 2012 to May 2014 were identified. Data from two patients were excluded because of intraoperative death. Patient data were then stratified into two groups, 'bleeding' [patients requiring re-laparotomy for bleeding control or transfusion of !3 units of red blood cells (RBCs) without operation within 48 h after admission to the ICU] and 'non-bleeding'.
Coagulation and transfusion management
In all patients, postoperative coagulation management was guided by ROTEM 
Statistical analysis
Data are presented as the mean (SD) if normally distributed, or as the median (25th-75th percentile) if non-normally distributed. Statistical calculations were performed with computer software (SPSS Statistics, Version 21.0; IBM, Armonk, NY, USA). Normally distributed data were compared using Student's unpaired t-tests, and non-normally distributed data were compared by Mann-Whitney U-tests. A two-tailed P-value of <0.05 was considered statistically significant.
Receiver operating characteristics (ROC) were used to assess the ability of SLTs and ROTEM V R values to identify patients with excessive postoperative bleeding. Areas under the respective ROC curves (AUCs) are provided as an overall measure of test
Editor's key points
• Postoperative bleeding remains an important cause of morbidity after liver transplantation.
• The utility of standard laboratory coagulation tests and thromboelastometry (ROTEM V R ) in predicting postoperative bleeding were compared.
• In this single-centre retrospective study, both standard and ROTEM V R assays of clotting time were predictive of bleeding, while ROTEM V R assays of fibrinogen polymerization were superior.
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performance. An AUC <0.6 was considered a failure to predict postoperative bleeding. The ROC curves of corresponding SLTs and ROTEM V R assays were statistically compared using the method of Hanley 
Results

Patient characteristics
From January 2012 to May 2014, 245 liver transplants were performed. Two patients failed to meet inclusion criteria, and consequently, 243 patients (144 male, 99 female) were included in our study. The mean age of the entire study population was 51 (11) yr, with a mean MELD score of 18 (9.5). The most common diagnoses were hepatitis C, alcohol-and non-alcohol-related cirrhosis, hepatocellular carcinoma, and cholestatic disease. The incidence of hepatocellular carcinoma in the non-bleeding group was signifcantly higher compared with the bleeding group (23 vs 3.3%, P¼0.014), whereas the incidence of cholestatic disease did not differ between groups (12.6 vs 13.3%, P<0.9). The median MELD score in the bleeding group was significantly higher compared with the non-bleeding group (22 vs 17, P<0.003). Patient data are presented in Table 1 .
Incidence of bleeding and impact on transfusion requirements
Thirty patients met criteria for inclusion in the bleeding group (12%); the remaining 213 patients were included in the nonbleeding group (88%). Of the 30 patients in the bleeding group, 23 (9.5%) underwent re-laparotomy and seven (2.9%) received !3 units of RBCs without surgical treatment. After surgery, patients in the bleeding group had a significantly higher transfusion rates for RBC, FFP, PC, PCC, FC, and FXIII (Table 2 and Fig. 1 ). Intraoperative transfusion requirements for blood, blood products, and coagulation factors are given in Table 2 and Fig. 1 . 
Standard laboratory tests
ROTEM V R analyses
On admission to the ICU, bleeding patients demonstrated a significantly longer CT EXTEM compared with non-bleeding patients [76 (26) vs 61 (28) s, P¼0.001]. Bleeding occurred 2.6 times more frequently in patients with a prolonged CT EXTEM . In the bleeding group, 40% of the CT EXTEM was pathological compared with 33% in the non-bleeding group. The FIBTEM V R amplitude was significantly lower in the bleeding group after 10 min (A10 FIBTEM ) compared with the non-bleeding group (9 vs 11 mm, P¼0.042). In addition, the MCF FIBTEM was also significantly lower in the bleeding group (10 vs 12 mm, P¼0.05). All other ROTEM V R parameters were not significantly different between groups.
Predicitve value of standard laboratory tests and thrombelastometry
Among SLTs, aPTT (AUC 0.688) and PT (AUC 0.623), but not fibrinogen concentration or platelet count, predicted postoperative Fig. 2 ).
Use of tranexamic acid
The use of tranexamic acid (was very low. Intraoperative use in both groups was 0 (0-0) g and was not significant different. Among the non-bleeding group, 26% of the patients received tranexamic acid compared with 27% in the bleeding group.
Discussion
Our study demonstrates that ROTEM V R -FIBTEM V R analyses were better predictors of postoperative bleeding than plasma fibrinogen concentrations in liver transplantation. ROTEM V R variables corresponding to PT and aPTT provided similar predictive value, whereas variables reflecting fibrinogen concentration and polymerization were significantly superior in ROTEM V R testing compared with plasma fibrinogen, which failed to predict bleeding.
Our findings indicate that ROTEM
V R -guided use of coagulation factors is more precise than treatment with blood components based on SLTs.
Our findings that select ROTEM V R variables predict bleeding after liver transplant are in agreement with previous studies. Fayed and colleagues 19 demonstrated that prolonged preoperative CT EXTEM is an independent predictor for RBC transfusion.
Fayed and colleagues 19 also demonstrated that prolonged CT EXTEM together with low A10 FIBTEM is predictive of the need for FFP transfusions during LT. In their study, cut-offs for the CT EXTEM predictive value for RBC and FFP transfusion were 62 and 67 s, respectively. These values are very close to the optimal cut-off for predicting postoperative bleeding as determined in our study (!65 s). In our study, CT EXTEM and A10 FIBTEM prolongation were predictive for postoperative bleeding. This indicates that the cut-off value for coagulation factor replacement might be well below the upper reference suggested by the manufacturer. Our study also demonstrates that the optimal cut-off value for fibrinogen administration was MCF FIBTEM of 7 mm. Similar results have been demonstrated in previous publications. Fayed and colleagues 19 found that cut-off values for MCF FIBTEM , predicting the need for FFP and cryoprecipitate transfusion, were 9.5 and 8.5 mm respectively. In contrast, Blasi and colleagues 9 demonstrated a considerably lower cut-off value for A10 FIBTEM (<8 mm), predicting the need for fibrinogen replacement, than the cut-off value determined in our study ( 13 mm) .
It is important to note that in our study, Youden index calculated cut-off values provide only a mathematical optimum. A clinically optimal cut-off could be either higher or lower depending on the risk-benefit asessment of treatment vs nontreatment of abnornal laboratory values. For example, applying the Youden cut-off from another study (A10 FIBTEM <8 mm) to our cohort would result in a significant increase in specificity (from 33 to 77%), whereas sensitivity would decrease (from 90 to 37%). 11 As a result, when choosing cut-off values for a treatment algorithm, one should consider the sensitivity and specificity of that cut-off in the risk-benefit analysis (e.g. bleeding vs thrombosis). Of the SLTs, only PT and aPTT, but not fibrinogen concentration or platelet count, were predictive of postoperative bleeding. As PT and aPTT assays reflect thrombin generation initiated via the extrinsic and intrinsic pathway, these variables can serve as indicators for coagulation factor replacement, FFP, or both. ROTEM V R analyses also provide data indicative of deficiencies in surgery, 21 and postpartum haemorrhage. 22 In LT, however, fibrinogen concentration alone was not predictive of postoperative bleeding (AUC 0.531). We found that A10 and MCF FIBTEM were predictive for bleeding (AUC >0.6). FIBTEM V R analysis, therefore, seems to be superior with regard to prediction of postoperative bleeding in LT patients. 23 A proposed explanation for these results is that with SLTs, there is an overestimation of fibrinogen in the presence of colloids. 24 We also found that both clot firmness variables (i.e. A10 and MCF) with EXTEM V R and INTEM V R assays and platelet count failed to predict postoperative bleeding in our cohort (AUC <0.6). In contrast, Blasi and colleagues 9 demonstrated that an A10 EXTEM of <35mm during LT was predictive of the need for platelet transfusion. It is important to note that the assessed optimal cut-off value for 'bleeding' prediction (A10 EXTEM 34 mm) in our study is very close to the cut-off demonstrated by Blasi and colleaguges 9 (A10 EXTEM 35 mm). However, the area under the ROC curve for the respective variable was <0.6 in our study and failed to predict bleeding according to our a priori definition. The failure of fibrinogen concentration and platelet count to predict postoperative bleeding hinders the establishment of goal-directed treatment algorithms based solely on SLTs. In contrast, ROTEM V R variables found to be predictive for postoperative bleeding in our study could be the basis for such algorithms. FIBTEM V R assays reflecting the fibrinogen concentration and fibrin polymerization could serve as indicators for the need for fibrinogen supplementation. As discussed above, A10 EXTEM appears to correlate well with the need for platelet transfusion. Therefore, it seems reasonable to establish goal-directed treatment algorithms based on ROTEM V R analyses rather than on SLTs. Another factor to be considered is turnaround time. ROTEM V R results in our study were available in <15 min and, more importantly, before the first signs of bleeding could be identified. Toulon and colleagues 5 (in an adult study) 25 Almost 10% of patients in our study required re-exploration for haemorrhage control, removal of haematoma, or both. Previous publications have demonstrated a higher incidence of re-bleeding in this patient population. Hendriks and colleagues 26 reported a reoperation rate because of non-surgical bleeding after LT of 16%. They also found that the in-hospital mortality increased to 21% in this patient group. A possible explanation for this finding is differences in coagulation management. In contrast to our investigation, 16 coagulation management and factor replacement in the study by Hendriks and colleagues 26 was based on SLTs. They also reported a median RBC replacement of 2 litres ($8 units of RBCs) despite routine use of aprotinin and platelet transfusion. In our experience, based on ROTEM V R coagulation management, the transfusion rate for RBCs decreased from 8 to 2 units of RBCs over 10 yr. 16 There are relatively few studies demonstrating the effectiveness of SLTs in directing coagulation management. In a metaanalysis, Haas and colleagues 7 failed to identify any randomized controlled trial (RCT) supporting the use of SLTs to guide coagulation management. De Pietri and colleagues 13 performed an RCT in cirrhotic patients comparing transfusion requirements after an invasive procedure. Either SLTs (control group) or viscoelastic tests (intervention group) were used to guide transfusion therapy. All patients in the control group received blood products (RBC, FFP, platelets), whereas only 17% in the intervention group required transfusion. Post-procedural haemoglobin in the intervention group was significantly higher, and the incidence of post-procedural bleeding was not different between groups. They concluded that there is no evidence to support the use of SLTs for coagulation management. It remains controversial, however, whether the use of viscoelastic tests reduces the transfusion rate during LT. 10 27 28 In a prospective follow-up study based on previous data, 23 Roullet and colleagues 29 evaluated transfusion requirements and coagulation management in two consecutive groups of patients having LT (with and without ROTEM V R guidance). The authors failed to demonstrate a decrease in transfusion rate in the ROTEM V R -guided coagulation management group. In an RCT, Wang and colleagues 30 demonstrated that TEG-guided coagulation management significantly reduced FFP transfusion compared with an SLT-based approach.
As a result of a significant number of RCTs demonstrating the efficacy of viscoelastic testing in the management of severe perioperative bleeding, the European Society of Anaesthesiology recommends the use of viscoelastic testing for coagulation management in this setting. 31 This study has some limitations. In addition to the study design itself (retrospective, single centre), cut-off values used for statistical analyses were calculated without accounting for potential risks and benefits of applying or withholding treatment. In addition, the indications for blood transfusion in our study were based on our institutional protocol. The use of a more restrictive transfusion protocol 32 33 might further reduce the amount of blood products administered.
Conclusion
Our study demonstrates that ROTEM V R analyses were better predictors of postoperative bleeding than SLTs in liver transplantation. ROTEM V R variables corresponding to PT and aPTT provided similar predictive value, but variables reflecting fibrinogen polymerization were significantly superior with ROTEM V R in comparison to plasma fibrinogen concentration, which failed to predict bleeding.
